DEVICES TO PREVENT CORONARY OBSTRUCTION AND ENABLERS OF LIVE MANAGEMENT

Tuesday, February 28, 2023

8:00 AM – 9:06 AM ET

Moderator(s)

Robert J. Lederman, MD

Senior Investigator, Chief, Laboratory of Cardiovascular Intervention
National Institutes of Health/National Heart, Lung, and Blood Institute
Bethesda, Maryland, United States

Disclosure(s): No financial relationships to disclose
Toby Rogers, MD, PhD

Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): Abbott: Advisory Committee/Board Member (Ongoing); Boston Scientific: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing); Edwards Lifesciences: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing); Transmural Systems: Consultant (Ongoing), Shareholder (Ongoing)

Disclosure(s):

Robert J. Lederman, MD: No financial relationships to disclose

Toby Rogers, MD, PhD: Abbott: Advisory Committee/Board Member (Ongoing); Boston Scientific: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing); Edwards Lifesciences: Consultant (Ongoing); Medtronic: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing); Transmural Systems: Consultant (Ongoing), Shareholder (Ongoing)